Thank you, Madam Chair.
We've learned today—at least I have—that because of certain dependency issues, you rely on others when making difficult decisions. I want to highlight your honesty in bringing this up. I'm not saying that this constitutes collusion. However, it will be worthwhile to hear what the Competition Bureau has to say about this.
I want to understand what steps you took. Did you discuss this temporary positive benefit—and I think that the word “temporary” is significant for this premium—before you put it in place?
My question is for Mr. Medline.